What is partial response vs complete response in Lung Cancer treatment
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Partial Response vs Complete Response in Lung Cancer Treatment
Great question—understanding these response categories helps you track how well your treatment is working and what your doctors are looking for on imaging scans.
Complete Response (CR)
A complete response means that all detectable cancer has disappeared on imaging studies (CT scans, PET scans, etc.). However, this doesn't necessarily mean every cancer cell is gone from your body—some microscopic disease might remain—but from a radiological standpoint, there's no visible tumor remaining.
What this means clinically:
- Your scans show no evidence of disease (often abbreviated as "NED")
- This is the best-case scenario doctors aim for
- It typically leads to better long-term outcomes
Partial Response (PR)
A partial response means your tumor has shrunk by at least 30% in size (measured by the longest diameter), but some cancer is still visible on imaging. The tumor hasn't disappeared, but treatment is clearly working.
What this means clinically:
- Your cancer is responding to treatment, but incompletely
- Doctors will continue monitoring to see if it shrinks further
- Treatment may continue, change, or be adjusted based on other factors
How Doctors Measure This
Oncologists use standardized measurement criteria called RECIST (Response Evaluation Criteria in Solid Tumors) to determine whether you have a complete response, partial response, stable disease, or progressive disease. They measure tumors on CT or PET scans and compare them to baseline scans taken before treatment started.
Why This Matters for Your Care
According to NCCN Guidelines for Non-Small Cell Lung Cancer, response assessment typically occurs:
- Every 8-12 weeks during active treatment
- At the end of planned treatment
- During follow-up surveillance
Your oncologist uses these response categories to decide whether to:
- Continue current treatment
- Switch to a different therapy
- Add additional treatments
- Move to maintenance therapy or surveillance
Questions to Ask Your Oncologist
- What type of response are we seeing on my scans? (Complete, partial, stable, or progressive?)
- How is this response compared to what you expected at this point in treatment?
- What's the plan if my response is partial rather than complete?
- How often will we reassess my response with imaging?
- What would trigger a change in my treatment plan?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lung Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What are the latest chemotherapy treatments for lung cancer in 2026
I appreciate your question about current treatment options. Let me explain what the latest evidence shows about chemotherapy for lung cancer, based on
What specific chemotherapy drugs are used for lung cancer and how do they work
I'm glad you're learning about treatment options. Let me explain the chemotherapy drugs commonly used for lung cancer and their mechanisms of action.
What are the common chemotherapy drugs and treatments for lung cancer
I'm glad you're learning about lung cancer treatment options. Let me explain the chemotherapy drugs and approaches that are commonly used, based on cu